83 Results
Dr Rajiv Desai on why India's next pharma milestone isn't cheaper generics, it's medicines the world calls Made in India.
Dr Rajiv Desai | Jul 15, 2026
A new parent leading baby care science at scale. Dr. Talluri on why clinical evidence — not marketing — is what consumers actually trust.
Dr. Siddhartha Talluri | Jun 23, 2026
Dr Santosh Indraksha topped UPSC, left J&J's global postings, and joined CDSCO. On Schedule M, 295 medicines during COVID-19, QR codes, and why AI must assist regulators but never replace them.
Dr Santosh Indraksha | Jun 22, 2026
Mehul Shah took 11 years to hit Rs 25 crore in turnover, then waited again before owning his own R&D. On the ₹250 stipend, building Volini, the PACO framework, and why patience beats speed in pharma.
Mr. Mehul Shah | Jun 18, 2026
Hemanth Panasa delayed an FDA inspection by 9 months and got zero observations. On aseptic failures, media fills, gowning myths, and why the biggest contamination risk in steriles is always human.
Mr. Hemanth Panasa | Jun 11, 2026
Naresh Kumar Gaur says pharma titles follow behaviour, not the other way around. Why most professionals are waiting for a crown they have to earn first.
Mr. Naresh Kumar Gaur | May 25, 2026
One question flipped pharma quality culture. Kasbi on why India still struggles with sustained compliance and what QA policing gets wrong.
Mr. Deepak Kasbi | May 02, 2026